欧洲老年医学培训要求2025:推动基于能力的教育和欧洲范围内的协调
Román Romero Ortuño1, Marianne van Iersel2, Maria S Nuotio3
1Discipline of Medical Gerontology, School of Medicine, Trinity College Dublin, Mercer's Institute for Successful Ageing, St James's Hospital, James's Street, Dublin, D08 NHY1, Ireland. romeroor@tcd.ie.
European geriatric medicine
|February 17, 2026
概括
"2025年老年医学欧洲培训要求" (ETR) 通过基于能力的框架和先进的评估工具更新了研究生标准. 这一修订旨在促进欧洲老年人的协调专业培训和高质量的护理.
科学领域:
- 老年医学 老年医学
- 医学教育 医学教育
- 医疗保健政策 医疗保健政策
背景情况:
- 欧洲医学专家联盟 - 老年医学部 (UEMS-GMS) 启动了老年医学欧洲培训要求 (ETR) 的修订.
- 目标是更新研究生培训标准,使其与该领域当前的科学,临床和教育进步保持一致.
研究的目的:
- 详细说明2025年修订的老年医学欧洲培训要求 (ETR) 的过程,内容和意义.
- 制定最新的欧洲研究生培训标准,反映最新的科学和临床进展.
主要方法:
- 根据UEMS官方程序,UEMS-GMS ETR审查委员会在2024年9月至2025年10月期间进行了修订.
- 该过程涉及建立在以前的课程基础上,纳入利益相关者的反,专家商,以及关键老年病学协会的国际认可.
- 最终文件得到了UEMS-GMS的正式批准,并得到了EuGMS,EAMA,IAGG和EICA的认可.
主要成果:
- 2025年ETR保持了UEMS三部分结构 (实习生,培训师,机构),同时引入了现代化,基于能力的教育框架.
- 更新的课程扩展了理论内容,并改进了它,以纳入最新的科学,临床和教学进展.
- 修订后的ETR强调可信任的专业活动 (EPA) 能力评估,并包括欧洲老年医学专业考试 (EGeMSE).
结论:
- 2025年ETR在欧洲和国际上推进了基于能力的,协调的老年医学专业培训.
- 该修订与全球卫生优先事项保持一致,例如联合国健康老龄化十年,加强教育卓越和以人为中心的老年人护理.
- 它支持新兴和不太成熟地区的老年医学的发展.
相关概念视频
Drug Dosing: Geriatric Patients
289
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
289
Pharmacodynamics in Geriatric Patients: Effects of Age
244
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
244
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
730
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
730
Peripheral Artery Disease III: Interprofessional Care
380
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
380
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
265
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
265
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
235
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
235


